BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 15951295)

  • 1. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
    Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
    Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
    Peng HL; Hu GY; Zhang GS; Gong FJ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in hereditary hemorrhagic telangiectasia: VEGF165 plasma concentration in correlation to the VEGF expression and microvessel density.
    Sadick H; Naim R; Gössler U; Hörmann K; Riedel F
    Int J Mol Med; 2005 Jan; 15(1):15-9. PubMed ID: 15583822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma level and tissue expression of angiogenic factors in patients with hereditary hemorrhagic telangiectasia.
    Sadick H; Naim R; Sadick M; Hörmann K; Riedel F
    Int J Mol Med; 2005 Apr; 15(4):591-6. PubMed ID: 15754019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
    Fujiwara M; Muragaki Y; Ooshima A
    Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
    Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
    Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2001; 12(3):445-52. PubMed ID: 11566625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
    Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
    Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia.
    Giordano P; Lenato GM; Pierucci P; Suppressa P; Altomare M; Del Vecchio G; Di Bitonto G; De Mattia D; Guanti G; Sabbà C
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):577-82. PubMed ID: 19636272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating angiogenic cytokines in multiple myeloma and related disorders.
    Urba ska-Rys H; Wierzbowska A; Robak T
    Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between transforming growth factor-beta1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis.
    Vural P; Degirmencioglu S; Erden S; Gelincik A
    Int Immunopharmacol; 2009 Feb; 9(2):212-5. PubMed ID: 19028605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.
    Carvalho RL; Jonker L; Goumans MJ; Larsson J; Bouwman P; Karlsson S; Dijke PT; Arthur HM; Mummery CL
    Development; 2004 Dec; 131(24):6237-47. PubMed ID: 15548578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S; Tsunoda T; Onuma E; Majima T; Kagiyama M; Kikuchi K
    Am J Gastroenterol; 2001 Mar; 96(3):822-8. PubMed ID: 11280558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta receptor function in the endothelium.
    Lebrin F; Deckers M; Bertolino P; Ten Dijke P
    Cardiovasc Res; 2005 Feb; 65(3):599-608. PubMed ID: 15664386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
    Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
    Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling.
    Seki T; Yun J; Oh SP
    Circ Res; 2003 Oct; 93(7):682-9. PubMed ID: 12970115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the genotype of HHT patients with mutations of the ENG and ACVRL1 gene correlate to different expression levels of the angiogenic factor VEGF?
    Sadick H; Hage J; Goessler U; Bran G; Riedel F; Bugert P; Hoermann K
    Int J Mol Med; 2008 Nov; 22(5):575-80. PubMed ID: 18949376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
    von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
    Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
    Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
    Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.